Innate Pharma (IPHA) Q1 2026 Earnings

26MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.35
-0.32
-0.29
-0.26

Details

Expected EPS
-0.352353
Actual EPS
-0.352353
Surprise EPS
0
Surprise Percent
+0%

Description

Innate Pharma (IPHA) has reported earnings of -0.352353 per share for Q1 2026.

0 Comments

Share your thoughts